Open original FDA record ↗Recall record
- FDA identifier
- Z-1674-2014
- Company in FDA record
- CryoLife, Inc.
- FDA classification date
- May 30, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Serum albumin component monomer failed to meet internally established end of shelf-life specification.
Source facts
- Action
- All consignees were notified of the voluntary actions by issuance of Field Correction/Removal Notice on April 24, 2014. This notices states which lot numbers are to be returned, and which lot numbers can be relabeled with a corrected expiration date.
- Initiated
- 2014-04-25
- Root cause
- Process control
- Terminated
- 2014-11-10
- Distribution
- Distributed Nationwide including Puerto Rico and the states of AL, AK,AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NV, NH, NJ, NM , NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, and WI.
- Recall number
- Z-1674-2014
- Recall status
- Terminated
- CDRH record ID
- 127033
- FDA classified
- 2014-05-30
- Recall event number
- 68150